Biobank Market Strengthened by New Biorepository Facilities

The global biobanks market was valued at USD 81.29 billion in 2024 and is projected to reach USD 126.69 billion by 2030, expanding at a CAGR of 7.85% from 2025 to 2030. This growth is primarily driven by substantial investments in R&D for advanced therapies, including regenerative medicine, personalized medicine, and cancer genomic studies.

Key Market Trends & Insights

  • Europe biobanks industry accounted for the largest revenue share of 39.37% in 2024.
  • The Asia Pacific biobanks industry is expected to witness the fastest CAGR over the forecast period.
  • Based on product & services, the services segment dominated the market and accounted for the largest revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period.
  • Based on biospecimen type, the human tissues segment captured the largest revenue share of 36.74% in 2024.
  • Based on biobanks type, the physical/real biobanks segment dominated the market in 2024 and accounted for the largest revenue share of 75.24%.
  • Based on application, the therapeutics application segment dominated the market with the largest revenue share of 37.63% in 2024.

Market Size & Forecast

  • 2024 Market Size: USD 81.29 Billion
  • 2030 Projected Market Size: USD 126.69 Billion
  • CAGR (2025-2030): 7.85%
  • Europe: Largest market in 2024
  • Asia Pacific: Fastest growing market

Growing adoption of precision medicine, genetic testing, and biomedical research continues to drive the market. Advances in genetic platforms and tools have boosted demand for high-quality biospecimens. Furthermore, collaborations between public and private institutions have enhanced the development of biobanking facilities and strengthened global market presence.

Order a free sample PDF of the Biobanks Market Intelligence Study, published by Grand View Research.

Key Biobanks Company Insights

Leading players are adopting both organic and inorganic strategies—including technological enhancements, service expansion, and collaborative partnerships—to strengthen their product portfolios and expand their global reach.

Key Biobanks Companies

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen
  • Hamilton Company
  • Tecan Trading AG
  • Danaher Corporation
  • Becton, Dickinson, and Company (BD)
  • Biocision, LLC
  • Taylor-Wharton
  • Charles River Laboratories
  • Lonza
  • Stemcell Technologies
  • Biovault Family
  • Promocell GmbH
  • Precision Cellular Storage Ltd. (Virgin Health Bank)

Conclusion

The biobanks market is poised for steady growth, fueled by rising investments in advanced therapeutic research, the expanding role of precision medicine, and the increasing need for high-quality biospecimens. The significant boost provided by COVID-19-related research has further strengthened the global biobanking infrastructure. With supportive government initiatives, technological advancements, and strategic partnerships, the market is expected to maintain strong momentum through 2030.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Urodynamic Equipment and Consumables Market Forecast: Anticipating Future Innovations

  The global urodynamic equipment and consumables market size is expected to reach USD 449.2 million in 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S. The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furtherm...
Read more

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more